TTM Technologies reported record Q2 revenue of $1.0B (+37% YoY) and non-GAAP EPS of $0.99 (+71% YoY), both above guidance, with adjusted EBITDA margin expanding 160 bps YoY to 16.6%. The company raised/updated its outlook to FY2026 revenue of ~$4.4B (tracking ahead toward at least $4B net sales) and expects Q3 revenue of $1.10B–$1.14B with non-GAAP EPS of $1.21–$1.27. Aerospace & Defense sales were $370M (+14% YoY) and Data Center/Networking sales were $400M (+91% YoY) as AI infrastructure demand accelerated; backlog strengthened with a 90-day backlog up 81% YoY to $901M. Management also guided to full-year margin improvement (gross margin 21.9%) alongside additional 2026 capex of $45M to support capacity expansion and pending acquisitions in Europe (closing in Q3).
TTMI is transitioning from a cyclical PCB supplier to a constrained-capacity supplier of mission-critical interconnect. That matters because AI/datacenter and defense customers pay for qualification, yield, and delivery certainty, not just sheet cost; the result is structurally better pricing power and a higher-quality backlog than the market typically assigns to electronics manufacturing names. Second-order winners are advanced material vendors and defense primes that need domestic, multi-site capacity; losers are lower-complexity PCB players and auto-oriented suppliers that are being de-prioritized in the supply chain.
The near-term bull case is still about execution, not demand. Management has effectively pre-sold a strong H2, so the stock now depends on N+M yield progression and whether the new capacity turns into margin, not just revenue. If Q3 or Q4 margins fail to inflect as promised, the multiple can compress quickly because the market is paying for a clean ramp story; watch book-to-bill, incremental gross margin, and FCF conversion over the next 1-2 quarters.
Contrarian view: consensus may be underestimating how much of the upside is already tied to one technology ramp and a narrow customer mix. The data-center leg can stay hot, but any AI capex digestion would hit TTMI harder than a broader industrial EMS name because the valuation is now tied to scarcity value. The best setup is to buy pullbacks, not chase strength, and to use relative value against a less differentiated peer where the market may eventually reward TTMI's superior mix and backlog visibility.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
moderately positive
Sentiment Score
0.70
Ticker Sentiment